Latest Breaking News On - Curis inc - Page 24 : comparemela.com

Esophageal Cancer Clinical Trial Pipeline Insights Featuring 80+ Companies

/PRNewswire/ DelveInsight s Esophageal Cancer Pipeline Insight – 2022 report provides comprehensive global coverage of available, marketed, and pipeline.

New yorkUnited statesUnited kingdomShruti thakurCelgene medimmuneDaiichi sankyoLyell immunopharmaEli lillyBristol myers squibbLetetresgene autoleucelAdlai nortyeAtreca incUniversity collaborations licensing partnering analysisTherapeutics assessmentby route of administrationChia tai tianqing pharmaceutical group co ltdJanssen research development

Imunon Appoints James E Dentzer to its Board of Directors

Imunon Appoints James E Dentzer to its Board of Directors
forextv.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from forextv.com Daily Mail and Mail on Sunday newspapers.

Michaelh tardugnoJamese dentzerKim sutton golodetzBoard of directors curis incJeffreyw churchBiogen incAmicus therapeutics incDicerna pharmaceuticals incCuris incExchange commissionImunon incImunon inc nasdaqValeritas incChief executive officerCuri chief operating officerChief financial

Imunon (IMNN) Appoints James E Dentzer to its Board

Imunon (IMNN) Appoints James E Dentzer to its Board
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Michaelh tardugnoJamese dentzerBoard of directors curis incImunon inc nasdaqValeritas incBiogen incAmicus therapeutics incCuris incDicerna pharmaceuticals incChief executive officerCuri chief operating officerChief financialFrom marchCuri chief administrative officerChief financial officerDicerna pharmaceuticals

Stock Market | FinancialContent Business Page

Stock Market | FinancialContent Business Page
financialcontent.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from financialcontent.com Daily Mail and Mail on Sunday newspapers.

Imunon Appoints James E Dentzer to its Board of Directors

03.10.2022 - CEO of Curis brings extensive biopharmaceutical financial experience to the Board LAWRENCEVILLE, N.J., Oct. 03, 2022 (GLOBE NEWSWIRE) - Imunon, Inc. (Nasdaq: IMNN), a clinical-stage drug development company, announces the appointment of James E. . Seite 1

Michaelh tardugnoJamese dentzerBoard of directors curis incImunon inc nasdaqValeritas incBiogen incAmicus therapeutics incCuris incDicerna pharmaceuticals incChief executive officerCuri chief operating officerChief financialFrom marchCuri chief administrative officerChief financial officerDicerna pharmaceuticals